JBSNF-000088 is a potent and selective inhibitor of the GLUT5 fructose transporter (SLC2A5). It is primarily utilized in biomedical and pharmaceutical research to investigate fructose metabolism and its implications in metabolic disorders such as obesity, diabetes, and non-alcoholic fatty liver disease. This compound aids in studying the role of GLUT5 in nutrient absorption and potential therapeutic targets for related conditions, including certain cancers where fructose uptake is elevated. As a research tool, it serves as an intermediate in drug discovery efforts aimed at modulating sugar transport pathways.